Morphine-3-glucuronide--a potent antagonist of morphine analgesia.
about
Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational studyAnalgesic effects of codeine-6-glucuronide after intravenous administrationMorphine induced allodynia in a child with brain tumour.Biotransformation and pharmacokinetics of ethylmorphine after a single oral dose.Morphine has latent deleterious effects on the ventilatory responses to a hypoxic challenge.Morphine has latent deleterious effects on the ventilatory responses to a hypoxic-hypercapnic challengeIntegrating palliative care with intensive care for critically ill patients with lung cancer.Pharmacokinetics of morphine infusion in premature neonates.The role of morphine glucuronides in cancer pain.Opioid rotation for cancer pain: rationale and clinical aspects.Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception.Tips and traps analyzing pediatric PK data.Bedside perspectives on the use of opioids: transferring results of clinical research into practice.Tremors and agitation following low-dose intravenous hydromorphone administration in a patient with kidney dysfunction.Respiratory depression following morphine and morphine-6-glucuronide in normal subjects.The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients.Morphine glucuronidation in premature neonatesIncreased clearance of morphine in sickle cell disease: implications for pain management.Mechanistic basis of altered morphine disposition in nonalcoholic steatohepatitis.A novel metabolic pathway of morphine: formation of morphine glucosides in cancer patients.Differential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioids.Sex differences in opioid analgesia: clinical and experimental findings.Relationship between morphine analgesia and cortical extracellular fluid levels of morphine and its metabolites in the rat: a microdialysis studyThe pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine.Stability studies of potent opioid analgesic, morphine-6-O-sulfate in various buffers and biological matrices by HPLC-DAD analysis.Effects of morphine metabolites on micturition in normal, unanaesthetized rats.Pharmacokinetics of Morphine and Its Metabolites in Infants and Young Children After Congenital Heart SurgeryNeuroexcitatory effects of morphine-3-glucuronide are dependent on Toll-like receptor 4 signaling.The use of opioid analgesia in end-stage renal disease patients managed without dialysis: recommendations for practice.Integration of palliative care in chronic critical illness managementA systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project.Perioperative management of the child on long-term opioids.Intracerebroventricular opioids for intractable pain.Pain in children--are we accomplishing the optimal pain treatment?Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide.An Expert Review of Pharmacogenomics of Sickle Cell Disease Therapeutics: Not Yet Ready for Global Precision Medicine.Opioid rotation from high-dose morphine to transdermal buprenorphine (Transtec) in chronic pain patients.Methadone in the intrathecal treatment of chronic nonmalignant pain resistant to other neuroaxial agents: the first experience.Morphine use and pharmacokinetics in patients with chest pain due to suspected or definite acute myocardial infarction.The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine.
P2860
Q24791044-479BBC60-5424-4641-B7A5-B94F74894089Q28257877-31603C22-50AC-4801-AFD9-A6649F5D0F0FQ28343557-AC0D9B80-737E-4B37-8E49-81C181CE3358Q28367979-1E14A457-B7D0-412A-ACB5-A33E6FBF1222Q30411852-21166868-6E5F-4D72-8DD3-CC2B1C7A31A0Q30411856-69997CE1-4AE9-4B17-8D06-F9B30430847EQ30427793-487E22DC-3E84-46C3-8284-5AAE0B9E8553Q33623615-0D742585-73BB-4A82-9040-8132D8D97620Q33727191-296289C3-C5B6-4F75-9700-86C4433198C6Q33765787-C2F40C76-EBF5-47C0-8164-EAFCEE0826F0Q33780850-766FA944-8175-46DC-8BD8-3BE496A1A3D3Q33820152-EDF78F00-91F8-48FE-AAE6-7773F21BD592Q33955130-F8D3F3CA-C0C4-4447-BB91-BA36CF3C4DE1Q34347201-BA013C57-FF58-4E3D-9536-3277666D90AFQ34347609-6081C3A0-48BD-4A02-8DAA-CBA894B019D3Q34403128-2C02C6C0-3A31-476B-97FE-9B7FA3AE1111Q34403737-CDB8389E-4CCB-435F-9CF0-A18B8A8D9C8FQ34917973-FF4E3277-27A8-4BD2-A76B-8957A0D441ACQ35156418-6F58B0E8-7161-4449-B154-2EE2E6C88C7BQ35825302-E5C88CAF-5475-4754-AC68-9242AFF8141BQ35827481-C7E64DD7-A62E-47DD-826D-2A2D61C4B952Q35868750-E77B9434-1067-44B5-880C-267379B4C0B1Q35873121-35768297-3C18-4726-AF66-24F92B85A5D6Q36055071-E6C6BC94-77A3-445F-A98F-69ADE4EBA14EQ36282135-D1F24AA6-A8CA-4E6D-8C3C-1FA30B98187CQ36330261-64727924-2B88-41BA-8083-D6DB513D2050Q36445122-891FD8E9-FF3B-4C2E-AB01-2EC1F619E37BQ36459833-9ECAA1DF-2B19-4A0B-A074-08D8CBB8032DQ36936202-84D79CFA-85DE-4159-B912-267B8266B81EQ37342206-DAB2A479-1310-499A-8A18-331AD3C054A0Q37895002-E9F65709-C266-4F58-9050-DD2FC5D9EC53Q37958058-1CA71BE1-38FA-4A61-92F4-6452E634E520Q37980479-E44A4498-B491-46A7-B7DE-26DDBD01458FQ38256422-B0FC32BF-5D18-495C-8D28-A37EA3908FE8Q38376713-C50D876E-A903-47C6-B9AB-0AC6F3D0B1EAQ38956275-C0322716-2E7C-407D-83FF-5EF308645C3FQ39334344-E2B4550D-DC41-4ED2-A44C-2BCEEAF439E6Q39423649-08061530-E383-40D7-A54A-03BC935C2155Q39432289-56757443-6105-4BA2-A2E7-3E89BDB0ADB7Q41170052-C356D55C-DCAD-4696-ABB4-35B35A3A410A
P2860
Morphine-3-glucuronide--a potent antagonist of morphine analgesia.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Morphine-3-glucuronide--a potent antagonist of morphine analgesia.
@en
Morphine-3-glucuronide--a potent antagonist of morphine analgesia.
@nl
type
label
Morphine-3-glucuronide--a potent antagonist of morphine analgesia.
@en
Morphine-3-glucuronide--a potent antagonist of morphine analgesia.
@nl
prefLabel
Morphine-3-glucuronide--a potent antagonist of morphine analgesia.
@en
Morphine-3-glucuronide--a potent antagonist of morphine analgesia.
@nl
P1433
P1476
Morphine-3-glucuronide--a potent antagonist of morphine analgesia.
@en
P2093
P304
P356
10.1016/0024-3205(90)90619-3
P407
P50
P577
1990-01-01T00:00:00Z